ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CGRP Targeting Drugs for Migraine Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-25U17807
Home | Market Reports | Health| Pharmacy
Global CGRP Targeting Drugs for Migraine Market Research Report 2024
BUY CHAPTERS

Global CGRP Targeting Drugs for Migraine Market Research Report 2024

Code: QYRE-Auto-25U17807
Report
August 2024
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Pfizer Inc
Lundbeck
TEVA
Lilly
Amgen Inc
Novartis International AG
Daiichi Sankyo Co Ltd
Alder Therapeutics

CGRP Targeting Drugs for Migraine Market

The main principle of drugs targeting CGRP for Migraine is to inhibit the biological effects of CGRP by blocking the binding of CGRP to its receptors, thereby achieving the purpose of treatment.
The global CGRP Targeting Drugs for Migraine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for CGRP Targeting Drugs for Migraine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CGRP Targeting Drugs for Migraine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CGRP Targeting Drugs for Migraine in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CGRP Targeting Drugs for Migraine include AbbVie Inc., Pfizer Inc., Lundbeck, Alder Therapeutics, Teva, Lilly Inc., Amgen Inc., Novartis International AG, Daiichi Sankyo Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CGRP Targeting Drugs for Migraine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CGRP Targeting Drugs for Migraine.
The CGRP Targeting Drugs for Migraine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CGRP Targeting Drugs for Migraine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CGRP Targeting Drugs for Migraine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of CGRP Targeting Drugs for Migraine Market Report

Report Metric Details
Report Name CGRP Targeting Drugs for Migraine Market
Segment by Type
Segment by Application
  • Hospital
  • Specialty Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie Inc., Pfizer Inc., Lundbeck, Alder Therapeutics, Teva, Lilly Inc., Amgen Inc., Novartis International AG, Daiichi Sankyo Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of CGRP Targeting Drugs for Migraine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CGRP Targeting Drugs for Migraine Market report?

Ans: The main players in the CGRP Targeting Drugs for Migraine Market are AbbVie Inc., Pfizer Inc., Lundbeck, Alder Therapeutics, Teva, Lilly Inc., Amgen Inc., Novartis International AG, Daiichi Sankyo Co., Ltd.

What are the Application segmentation covered in the CGRP Targeting Drugs for Migraine Market report?

Ans: The Applications covered in the CGRP Targeting Drugs for Migraine Market report are Hospital, Specialty Clinic, Others

What are the Type segmentation covered in the CGRP Targeting Drugs for Migraine Market report?

Ans: The Types covered in the CGRP Targeting Drugs for Migraine Market report are CGRP Receptor Antagonists, CGRP Monoclonal Antibodies

Recommended Reports

Pain Management Drugs

Neurological Disease Therapeutics

Targeted Therapy Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CGRP Targeting Drugs for Migraine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CGRP Receptor Antagonists
1.2.3 CGRP Monoclonal Antibodies
1.3 Market by Application
1.3.1 Global CGRP Targeting Drugs for Migraine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CGRP Targeting Drugs for Migraine Market Perspective (2019-2030)
2.2 Global CGRP Targeting Drugs for Migraine Growth Trends by Region
2.2.1 Global CGRP Targeting Drugs for Migraine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CGRP Targeting Drugs for Migraine Historic Market Size by Region (2019-2024)
2.2.3 CGRP Targeting Drugs for Migraine Forecasted Market Size by Region (2025-2030)
2.3 CGRP Targeting Drugs for Migraine Market Dynamics
2.3.1 CGRP Targeting Drugs for Migraine Industry Trends
2.3.2 CGRP Targeting Drugs for Migraine Market Drivers
2.3.3 CGRP Targeting Drugs for Migraine Market Challenges
2.3.4 CGRP Targeting Drugs for Migraine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CGRP Targeting Drugs for Migraine Players by Revenue
3.1.1 Global Top CGRP Targeting Drugs for Migraine Players by Revenue (2019-2024)
3.1.2 Global CGRP Targeting Drugs for Migraine Revenue Market Share by Players (2019-2024)
3.2 Global CGRP Targeting Drugs for Migraine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CGRP Targeting Drugs for Migraine Revenue
3.4 Global CGRP Targeting Drugs for Migraine Market Concentration Ratio
3.4.1 Global CGRP Targeting Drugs for Migraine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CGRP Targeting Drugs for Migraine Revenue in 2023
3.5 Global Key Players of CGRP Targeting Drugs for Migraine Head office and Area Served
3.6 Global Key Players of CGRP Targeting Drugs for Migraine, Product and Application
3.7 Global Key Players of CGRP Targeting Drugs for Migraine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CGRP Targeting Drugs for Migraine Breakdown Data by Type
4.1 Global CGRP Targeting Drugs for Migraine Historic Market Size by Type (2019-2024)
4.2 Global CGRP Targeting Drugs for Migraine Forecasted Market Size by Type (2025-2030)
5 CGRP Targeting Drugs for Migraine Breakdown Data by Application
5.1 Global CGRP Targeting Drugs for Migraine Historic Market Size by Application (2019-2024)
5.2 Global CGRP Targeting Drugs for Migraine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CGRP Targeting Drugs for Migraine Market Size (2019-2030)
6.2 North America CGRP Targeting Drugs for Migraine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CGRP Targeting Drugs for Migraine Market Size by Country (2019-2024)
6.4 North America CGRP Targeting Drugs for Migraine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CGRP Targeting Drugs for Migraine Market Size (2019-2030)
7.2 Europe CGRP Targeting Drugs for Migraine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CGRP Targeting Drugs for Migraine Market Size by Country (2019-2024)
7.4 Europe CGRP Targeting Drugs for Migraine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CGRP Targeting Drugs for Migraine Market Size (2019-2030)
8.2 Asia-Pacific CGRP Targeting Drugs for Migraine Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CGRP Targeting Drugs for Migraine Market Size by Region (2019-2024)
8.4 Asia-Pacific CGRP Targeting Drugs for Migraine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CGRP Targeting Drugs for Migraine Market Size (2019-2030)
9.2 Latin America CGRP Targeting Drugs for Migraine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CGRP Targeting Drugs for Migraine Market Size by Country (2019-2024)
9.4 Latin America CGRP Targeting Drugs for Migraine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CGRP Targeting Drugs for Migraine Market Size (2019-2030)
10.2 Middle East & Africa CGRP Targeting Drugs for Migraine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Country (2019-2024)
10.4 Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Company Details
11.1.2 AbbVie Inc. Business Overview
11.1.3 AbbVie Inc. CGRP Targeting Drugs for Migraine Introduction
11.1.4 AbbVie Inc. Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024)
11.1.5 AbbVie Inc. Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Details
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. CGRP Targeting Drugs for Migraine Introduction
11.2.4 Pfizer Inc. Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024)
11.2.5 Pfizer Inc. Recent Development
11.3 Lundbeck
11.3.1 Lundbeck Company Details
11.3.2 Lundbeck Business Overview
11.3.3 Lundbeck CGRP Targeting Drugs for Migraine Introduction
11.3.4 Lundbeck Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024)
11.3.5 Lundbeck Recent Development
11.4 Alder Therapeutics
11.4.1 Alder Therapeutics Company Details
11.4.2 Alder Therapeutics Business Overview
11.4.3 Alder Therapeutics CGRP Targeting Drugs for Migraine Introduction
11.4.4 Alder Therapeutics Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024)
11.4.5 Alder Therapeutics Recent Development
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva CGRP Targeting Drugs for Migraine Introduction
11.5.4 Teva Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024)
11.5.5 Teva Recent Development
11.6 Lilly Inc.
11.6.1 Lilly Inc. Company Details
11.6.2 Lilly Inc. Business Overview
11.6.3 Lilly Inc. CGRP Targeting Drugs for Migraine Introduction
11.6.4 Lilly Inc. Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024)
11.6.5 Lilly Inc. Recent Development
11.7 Amgen Inc.
11.7.1 Amgen Inc. Company Details
11.7.2 Amgen Inc. Business Overview
11.7.3 Amgen Inc. CGRP Targeting Drugs for Migraine Introduction
11.7.4 Amgen Inc. Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024)
11.7.5 Amgen Inc. Recent Development
11.8 Novartis International AG
11.8.1 Novartis International AG Company Details
11.8.2 Novartis International AG Business Overview
11.8.3 Novartis International AG CGRP Targeting Drugs for Migraine Introduction
11.8.4 Novartis International AG Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024)
11.8.5 Novartis International AG Recent Development
11.9 Daiichi Sankyo Co., Ltd.
11.9.1 Daiichi Sankyo Co., Ltd. Company Details
11.9.2 Daiichi Sankyo Co., Ltd. Business Overview
11.9.3 Daiichi Sankyo Co., Ltd. CGRP Targeting Drugs for Migraine Introduction
11.9.4 Daiichi Sankyo Co., Ltd. Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024)
11.9.5 Daiichi Sankyo Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
AbbVie
Pfizer Inc
Lundbeck
TEVA
Lilly
Amgen Inc
Novartis International AG
Daiichi Sankyo Co Ltd
Alder Therapeutics
List of Tables
 Table 1. Global CGRP Targeting Drugs for Migraine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of CGRP Receptor Antagonists
 Table 3. Key Players of CGRP Monoclonal Antibodies
 Table 4. Global CGRP Targeting Drugs for Migraine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global CGRP Targeting Drugs for Migraine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global CGRP Targeting Drugs for Migraine Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global CGRP Targeting Drugs for Migraine Market Share by Region (2019-2024)
 Table 8. Global CGRP Targeting Drugs for Migraine Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global CGRP Targeting Drugs for Migraine Market Share by Region (2025-2030)
 Table 10. CGRP Targeting Drugs for Migraine Market Trends
 Table 11. CGRP Targeting Drugs for Migraine Market Drivers
 Table 12. CGRP Targeting Drugs for Migraine Market Challenges
 Table 13. CGRP Targeting Drugs for Migraine Market Restraints
 Table 14. Global CGRP Targeting Drugs for Migraine Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global CGRP Targeting Drugs for Migraine Market Share by Players (2019-2024)
 Table 16. Global Top CGRP Targeting Drugs for Migraine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CGRP Targeting Drugs for Migraine as of 2023)
 Table 17. Ranking of Global Top CGRP Targeting Drugs for Migraine Companies by Revenue (US$ Million) in 2023
 Table 18. Global 5 Largest Players Market Share by CGRP Targeting Drugs for Migraine Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of CGRP Targeting Drugs for Migraine, Headquarters and Area Served
 Table 20. Global Key Players of CGRP Targeting Drugs for Migraine, Product and Application
 Table 21. Global Key Players of CGRP Targeting Drugs for Migraine, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global CGRP Targeting Drugs for Migraine Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global CGRP Targeting Drugs for Migraine Revenue Market Share by Type (2019-2024)
 Table 25. Global CGRP Targeting Drugs for Migraine Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global CGRP Targeting Drugs for Migraine Revenue Market Share by Type (2025-2030)
 Table 27. Global CGRP Targeting Drugs for Migraine Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global CGRP Targeting Drugs for Migraine Revenue Market Share by Application (2019-2024)
 Table 29. Global CGRP Targeting Drugs for Migraine Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global CGRP Targeting Drugs for Migraine Revenue Market Share by Application (2025-2030)
 Table 31. North America CGRP Targeting Drugs for Migraine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 32. North America CGRP Targeting Drugs for Migraine Market Size by Country (2019-2024) & (US$ Million)
 Table 33. North America CGRP Targeting Drugs for Migraine Market Size by Country (2025-2030) & (US$ Million)
 Table 34. Europe CGRP Targeting Drugs for Migraine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. Europe CGRP Targeting Drugs for Migraine Market Size by Country (2019-2024) & (US$ Million)
 Table 36. Europe CGRP Targeting Drugs for Migraine Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Asia-Pacific CGRP Targeting Drugs for Migraine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Asia-Pacific CGRP Targeting Drugs for Migraine Market Size by Region (2019-2024) & (US$ Million)
 Table 39. Asia-Pacific CGRP Targeting Drugs for Migraine Market Size by Region (2025-2030) & (US$ Million)
 Table 40. Latin America CGRP Targeting Drugs for Migraine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Latin America CGRP Targeting Drugs for Migraine Market Size by Country (2019-2024) & (US$ Million)
 Table 42. Latin America CGRP Targeting Drugs for Migraine Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Middle East & Africa CGRP Targeting Drugs for Migraine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Country (2025-2030) & (US$ Million)
 Table 46. AbbVie Inc. Company Details
 Table 47. AbbVie Inc. Business Overview
 Table 48. AbbVie Inc. CGRP Targeting Drugs for Migraine Product
 Table 49. AbbVie Inc. Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024) & (US$ Million)
 Table 50. AbbVie Inc. Recent Development
 Table 51. Pfizer Inc. Company Details
 Table 52. Pfizer Inc. Business Overview
 Table 53. Pfizer Inc. CGRP Targeting Drugs for Migraine Product
 Table 54. Pfizer Inc. Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024) & (US$ Million)
 Table 55. Pfizer Inc. Recent Development
 Table 56. Lundbeck Company Details
 Table 57. Lundbeck Business Overview
 Table 58. Lundbeck CGRP Targeting Drugs for Migraine Product
 Table 59. Lundbeck Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024) & (US$ Million)
 Table 60. Lundbeck Recent Development
 Table 61. Alder Therapeutics Company Details
 Table 62. Alder Therapeutics Business Overview
 Table 63. Alder Therapeutics CGRP Targeting Drugs for Migraine Product
 Table 64. Alder Therapeutics Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024) & (US$ Million)
 Table 65. Alder Therapeutics Recent Development
 Table 66. Teva Company Details
 Table 67. Teva Business Overview
 Table 68. Teva CGRP Targeting Drugs for Migraine Product
 Table 69. Teva Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024) & (US$ Million)
 Table 70. Teva Recent Development
 Table 71. Lilly Inc. Company Details
 Table 72. Lilly Inc. Business Overview
 Table 73. Lilly Inc. CGRP Targeting Drugs for Migraine Product
 Table 74. Lilly Inc. Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024) & (US$ Million)
 Table 75. Lilly Inc. Recent Development
 Table 76. Amgen Inc. Company Details
 Table 77. Amgen Inc. Business Overview
 Table 78. Amgen Inc. CGRP Targeting Drugs for Migraine Product
 Table 79. Amgen Inc. Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024) & (US$ Million)
 Table 80. Amgen Inc. Recent Development
 Table 81. Novartis International AG Company Details
 Table 82. Novartis International AG Business Overview
 Table 83. Novartis International AG CGRP Targeting Drugs for Migraine Product
 Table 84. Novartis International AG Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024) & (US$ Million)
 Table 85. Novartis International AG Recent Development
 Table 86. Daiichi Sankyo Co., Ltd. Company Details
 Table 87. Daiichi Sankyo Co., Ltd. Business Overview
 Table 88. Daiichi Sankyo Co., Ltd. CGRP Targeting Drugs for Migraine Product
 Table 89. Daiichi Sankyo Co., Ltd. Revenue in CGRP Targeting Drugs for Migraine Business (2019-2024) & (US$ Million)
 Table 90. Daiichi Sankyo Co., Ltd. Recent Development
 Table 91. Research Programs/Design for This Report
 Table 92. Key Data Information from Secondary Sources
 Table 93. Key Data Information from Primary Sources
 Table 94. Authors List of This Report


List of Figures
 Figure 1. CGRP Targeting Drugs for Migraine Picture
 Figure 2. Global CGRP Targeting Drugs for Migraine Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global CGRP Targeting Drugs for Migraine Market Share by Type: 2023 VS 2030
 Figure 4. CGRP Receptor Antagonists Features
 Figure 5. CGRP Monoclonal Antibodies Features
 Figure 6. Global CGRP Targeting Drugs for Migraine Market Size by Application (2024-2030) & (US$ Million)
 Figure 7. Global CGRP Targeting Drugs for Migraine Market Share by Application: 2023 VS 2030
 Figure 8. Hospital Case Studies
 Figure 9. Specialty Clinic Case Studies
 Figure 10. Others Case Studies
 Figure 11. CGRP Targeting Drugs for Migraine Report Years Considered
 Figure 12. Global CGRP Targeting Drugs for Migraine Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 13. Global CGRP Targeting Drugs for Migraine Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global CGRP Targeting Drugs for Migraine Market Share by Region: 2023 VS 2030
 Figure 15. Global CGRP Targeting Drugs for Migraine Market Share by Players in 2023
 Figure 16. Global Top CGRP Targeting Drugs for Migraine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CGRP Targeting Drugs for Migraine as of 2023)
 Figure 17. The Top 10 and 5 Players Market Share by CGRP Targeting Drugs for Migraine Revenue in 2023
 Figure 18. North America CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 19. North America CGRP Targeting Drugs for Migraine Market Share by Country (2019-2030)
 Figure 20. United States CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe CGRP Targeting Drugs for Migraine Market Share by Country (2019-2030)
 Figure 24. Germany CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. France CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. U.K. CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Italy CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Russia CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Nordic Countries CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific CGRP Targeting Drugs for Migraine Market Share by Region (2019-2030)
 Figure 32. China CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Japan CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. South Korea CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Southeast Asia CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. India CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Australia CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America CGRP Targeting Drugs for Migraine Market Share by Country (2019-2030)
 Figure 40. Mexico CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Brazil CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa CGRP Targeting Drugs for Migraine Market Share by Country (2019-2030)
 Figure 44. Turkey CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Saudi Arabia CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. UAE CGRP Targeting Drugs for Migraine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. AbbVie Inc. Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2019-2024)
 Figure 48. Pfizer Inc. Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2019-2024)
 Figure 49. Lundbeck Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2019-2024)
 Figure 50. Alder Therapeutics Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2019-2024)
 Figure 51. Teva Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2019-2024)
 Figure 52. Lilly Inc. Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2019-2024)
 Figure 53. Amgen Inc. Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2019-2024)
 Figure 54. Novartis International AG Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2019-2024)
 Figure 55. Daiichi Sankyo Co., Ltd. Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2019-2024)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global CGRP Receptor Antagonists Market Research Report 2024
Migraine Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Migraine Drugs Market Research Report 2025
Global Oral Migraine Drugs Market Research Report 2025
Rimegepant API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Migraine Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CGRP Monoclonal Antibodies Market Research Report 2024
Migraine Treatment Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Preventive Treatment of Migraines Market Research Report 2024
Prescription Migraine Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Migraine Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Migraine Treatment Market Research Report 2024
Migraine Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Triptans for Migraine Headaches Market Research Report 2025
Migraine Headache Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CGRP Antagonists Market Research Report 2024
Cluster Headache Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tumor Targeting Peptides Market Research Report 2024
Prescription Headache Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gepants Drugs Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions